openPR Logo
Press release

Overactive Bladder (OAB) Therapeutics Market: Global Industry Size, Share, Growth, Trends and Forecast by 2021

02-25-2018 08:36 AM CET | Health & Medicine

Press release from: Persistence Market Research

Overactive Bladder (OAB) Therapeutics Market: Global Industry

Overactive bladder is a medical syndrome, defined by urinary incontinence usually characterized by high urine frequency or nocturia. The common symptoms of OAB includes urgency, high urinary frequency and urge incontinence. Anticholinergic agents are considered as the first line treatment for overactive bladder disorders. Flavoxate, oxybutynin, tolterodine are some of the generic drugs used for the treatment of overactive bladder. These drugs acts by antagonizing cholinergic receptors that provides the relief from the frequent urination. 

Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/5612

Increasing population diagnosed with overactive bladder disorder coupled with aging population will drive the growth of this market. Furthermore, manufacturers are continuously increasing their research and development expenditure to develop novel drugs such as neuromuscular blocking agents with innovative mechanism of actions. This factor will provide healthy platform to develop this market and hence drives the market growth. In addition, efforts of many key players launching consumer campaigns aiming to increase the awareness of this disorder among the people will further boost the growth of this market. However, patent expiry of the key drugs namely Oxytrol, Toviaz and Detrol may significantly restrain the growth of this market. Unfavorable side effect such as bladder muscle contraction, mental confusion, dry mouth and constipation coupled with low efficacy of available drugs will also restrain the growth of this market.

Geographically, North America is considered to be the largest market of overactive bladder therapeutics owing to introduction of advanced techniques for the treatment of these disorder. Europe is considered as second largest market of overactive bladder therapeutics. The growth is mainly attributed to widespread availability of generic drugs for the treatment of this disorder. In addition, Asia-Pacific region is the emerging markets for overactive bladder therapeutics market because of rising healthcare awareness among the people.

Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/5612

Various key players contributing to the global overactive bladder therapeutics market includes Allergan, Inc. , Antares Pharma, Inc , Astellas Pharma, Inc., Hisamitsu Pharmaceutical Co., Inc., Teva Pharmaceutical Industries Limited  and others.

Key feaures of this report

Drivers, restraints, and challenges shaping the Overactive Bladder (OAB) Therapeutics market dynamics
Latest innovations and key events in the industry
Analysis of business strategies of the top players
Overactive Bladder (OAB) Therapeutics market estimates and forecasts(2015 -2021)

Need more information about Report methodology ? @ https://www.persistencemarketresearch.com/methodology/5612

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

Telephone - +1-646-568-7751

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Overactive Bladder (OAB) Therapeutics Market: Global Industry Size, Share, Growth, Trends and Forecast by 2021 here

News-ID: 956327 • Views:

More Releases from Persistence Market Research

Digital Crosspoint Switches Market Anticipated to Hit USD 52.5 Billion by 2032
Digital Crosspoint Switches Market Anticipated to Hit USD 52.5 Billion by 2032
Overview of the Digital Crosspoint Switches Market The global digital crosspoint switches market is expected to be valued at US$ 28.9 billion in 2025, with projections to reach US$ 52.5 billion by 2032, growing at a robust CAGR of 8.9% during the forecast period. This growth is fueled by the surging need for high-speed data transmission, the expansion of next-generation telecommunications networks, and the increasing deployment of data centers worldwide. As
Multiformat Transcoders Market Estimated to Grow at 8.6% CAGR by 2032
Multiformat Transcoders Market Estimated to Grow at 8.6% CAGR by 2032
Overview of the Multiformat Transcoders Market The global multiformat transcoders market is poised for remarkable expansion, with an estimated valuation of US$ 1.3 billion in 2025, projected to reach US$ 2.3 billion by 2032. This growth trajectory represents a robust CAGR of 8.6% during the forecast period (2025-2032). The market's expansion is driven by the surging demand for high-quality video streaming, advancements in cloud-based transcoding technologies, and the rising consumption of
Automotive Bearing and Clutch Component Aftermarket Set for 4.5% CAGR Growth, Surpassing US$ 7.2 Billion by 2031
Automotive Bearing and Clutch Component Aftermarket Set for 4.5% CAGR Growth, Su …
The global automotive bearing and clutch component aftermarket is poised for steady expansion over the forecast period. According to the latest findings from Persistence Market Research, the market is projected to grow from an estimated US$ 5.3 billion in 2024 to approximately US$ 7.2 billion by 2031, reflecting a compound annual growth rate (CAGR) of 4.5%. This market covers the replacement of bearings, clutch kits, and related clutch components that
Compound Semiconductor Material Industry Forecasted to Grow at a 7.2% CAGR, Surpassing USD 63 Billion by 2032
Compound Semiconductor Material Industry Forecasted to Grow at a 7.2% CAGR, Surp …
Overview of the Compound Semiconductor Material Market The global compound semiconductor material market is projected to be valued at US$38.7 billion in 2025, reaching approximately US$63.0 billion by 2032, growing at a robust CAGR of 7.2% from 2025 to 2032. This remarkable growth is driven by the increasing integration of wide-bandgap materials such as Gallium Nitride (GaN) and Silicon Carbide (SiC) across key applications, including electric vehicles (EVs), renewable energy systems,

All 5 Releases


More Releases for Overactive

Emerging Trends Influencing The Growth Of The Overactive Bladder Treatment Marke …
The Overactive Bladder Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Overactive Bladder Treatment Market? The market size for overactive bladder treatments has been consistently expanding over the past few years. The market is projected to increase from
Emerging Trends Influencing The Growth Of The Overactive Bladder Treatment Marke …
The Overactive Bladder Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Overactive Bladder Treatment Market? The market size for overactive bladder treatments has been consistently expanding over the past few years. The market is projected to increase from
Top Factor Driving Overactive Bladder Treatment Market Growth in 2025: Geriatric …
What industry-specific factors are fueling the growth of the overactive bladder treatment market? The anticipated growth of the overactive bladder treatment market is largely attributed to an increasing geriatric population. This term pertains to individuals who are 65 years old and above. The susceptibility of geriatric patients to urinary tract infections is higher due to multiple factors like reduced urine flow, overactive bladder, enlarged prostate or presence of kidney stones, thereby
Overactive Bladder Market - Empowering Life Without Limits: Overactive Bladder S …
Newark, New Castle, USA - new report, titled Overactive Bladder Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Overactive Bladder market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Overactive Bladder market. The report offers an overview of the market, which
Overactive Bladder Market Report, History and Forecast 2022-2030
Overactive Bladder Market 2021 by Technology, Manufacturers, Regions, Type, and Application, Forecast guide to light the excellent analysis on the market synopsis. The report offers a primary focus on important factors in the global Overactive Bladder industry. The report includes perceptive information about gross revenue, cost, value, capacity, pricing, and profit margins concerning historical analysis and forecast estimation for the 2021 to 2031 time period. It presents a close overview
Overactive Bladder Treatment Market by Drug Type (Anticholinergics, Mirabegron, …
Market Analysis and Insights of Overactive Bladder Treatment Market During the forecasted period of 2023-2032, the market for treatments for overactive bladder will grow at a CAGR of about 4.00%. The main drivers of the overactive bladder treatment market's expansion are the rising prevalence of kidney-related disorders, increased emphasis on medical device research and development expertise and the adoption of cutting-edge IT healthcare technologies, an increasing geriatric population worldwide, and rising